Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 86

1.

Ras-induced ROS upregulation affecting cell proliferation is connected with cell type-specific alterations of HSF1/SESN3/p21Cip1/WAF1 pathways.

Zamkova M, Khromova N, Kopnin BP, Kopnin P.

Cell Cycle. 2013 Mar 1;12(5):826-36. doi: 10.4161/cc.23723. Epub 2013 Feb 6.

2.

Downregulation of VEGF-C expression in lung and colon cancer cells decelerates tumor growth and inhibits metastasis via multiple mechanisms.

Khromova N, Kopnin P, Rybko V, Kopnin BP.

Oncogene. 2012 Mar 15;31(11):1389-97. doi: 10.1038/onc.2011.330. Epub 2011 Aug 1.

PMID:
21804602
3.

An attempt to prevent senescence: a mitochondrial approach.

Skulachev VP, Anisimov VN, Antonenko YN, Bakeeva LE, Chernyak BV, Erichev VP, Filenko OF, Kalinina NI, Kapelko VI, Kolosova NG, Kopnin BP, Korshunova GA, Lichinitser MR, Obukhova LA, Pasyukova EG, Pisarenko OI, Roginsky VA, Ruuge EK, Senin II, Severina II, Skulachev MV, Spivak IM, Tashlitsky VN, Tkachuk VA, Vyssokikh MY, Yaguzhinsky LS, Zorov DB.

Biochim Biophys Acta. 2009 May;1787(5):437-61. doi: 10.1016/j.bbabio.2008.12.008. Epub 2008 Dec 29. Review.

4.

Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells.

Agapova LS, Chernyak BV, Domnina LV, Dugina VB, Efimenko AY, Fetisova EK, Ivanova OY, Kalinina NI, Khromova NV, Kopnin BP, Kopnin PB, Korotetskaya MV, Lichinitser MR, Lukashev AL, Pletjushkina OY, Popova EN, Skulachev MV, Shagieva GS, Stepanova EV, Titova EV, Tkachuk VA, Vasiliev JM, Skulachev VP.

Biochemistry (Mosc). 2008 Dec;73(12):1300-16.

5.

p53 hot-spot mutants increase tumor vascularization via ROS-mediated activation of the HIF1/VEGF-A pathway.

Khromova NV, Kopnin PB, Stepanova EV, Agapova LS, Kopnin BP.

Cancer Lett. 2009 Apr 18;276(2):143-51. doi: 10.1016/j.canlet.2008.10.049. Epub 2008 Dec 16.

PMID:
19091459
6.

[Progress in understanding moleculr mechanisms of oncogenesis, and novel methods of tumor growth control].

Agapova LS, Kopnin BP.

Vestn Ross Akad Med Nauk. 2007;(11):3-9. Review. Russian.

PMID:
18080521
7.

[Genome instability and oncogenesis].

Kopnin BP.

Mol Biol (Mosk). 2007 Mar-Apr;41(2):369-80. Review. Russian.

PMID:
17514903
8.
9.

ROS up-regulation mediates Ras-induced changes of cell morphology and motility.

Alexandrova AY, Kopnin PB, Vasiliev JM, Kopnin BP.

Exp Cell Res. 2006 Jul 1;312(11):2066-73. Epub 2006 Apr 19.

PMID:
16624288
10.

Cell type-specific effects of asbestos on intracellular ROS levels, DNA oxidation and G1 cell cycle checkpoint.

Kopnin PB, Kravchenko IV, Furalyov VA, Pylev LN, Kopnin BP.

Oncogene. 2004 Nov 18;23(54):8834-40.

PMID:
15480427
11.

Activation of Ras-Ral pathway attenuates p53-independent DNA damage G2 checkpoint.

Agapova LS, Volodina JL, Chumakov PM, Kopnin BP.

J Biol Chem. 2004 Aug 27;279(35):36382-9. Epub 2004 Jun 18.

12.

Restoration of p53 tumor-suppressor activity in human tumor cells in vitro and in their xenografts in vivo by recombinant avian adenovirus CELO-p53.

Logunov DY, Ilyinskaya GV, Cherenova LV, Verhovskaya LV, Shmarov MM, Chumakov PM, Kopnin BP, Naroditsky BS.

Gene Ther. 2004 Jan;11(1):79-84.

PMID:
14681700
13.

[The protective role of p53 in Ras-induced transformation of REF52 cells].

Kopnin PB, Ivanov AV, Il'inskaia GV, Sablina AA, Kopnin BP, Chumakov PM.

Mol Biol (Mosk). 2003 May-Jun;37(3):458-71. Russian.

PMID:
12815953
14.

Tumor suppressor p53 and its homologue p73alpha affect cell migration.

Sablina AA, Chumakov PM, Kopnin BP.

J Biol Chem. 2003 Jul 25;278(30):27362-71. Epub 2003 May 15.

15.

[Dominant-negative inactivation of p53: the effect of the proportion between trans-dominant inhibitor and its target].

Morgunkova AA, Almazov VP, Strunina SM, Kopnin BP, Chumakov PM.

Mol Biol (Mosk). 2003 Jan-Feb;37(1):112-20. Russian.

PMID:
12624953
16.

[Construction of chimeric tumor suppressor p53 resistant to the dominant-negative interaction with p53 mutants].

Almazov VP, Morgunkova AA, Kalinin VN, Kopnin BP, Prasolov VS, Chumakov PM.

Mol Biol (Mosk). 2002 Jul-Aug;36(4):664-71. Russian.

PMID:
12173471
17.

Novel gain of function activity of p53 mutants: activation of the dUTPase gene expression leading to resistance to 5-fluorouracil.

Pugacheva EN, Ivanov AV, Kravchenko JE, Kopnin BP, Levine AJ, Chumakov PM.

Oncogene. 2002 Jul 11;21(30):4595-600.

18.

p53 activation in response to microtubule disruption is mediated by integrin-Erk signaling.

Sablina AA, Chumakov PM, Levine AJ, Kopnin BP.

Oncogene. 2001 Feb 22;20(8):899-909.

19.

[Mutation of p53 is necessary for stable transformation of REF52 cells by myc+ras oncogenes].

Ivanov AV, Kopnin PB, Kondratov RV, Osovskaia VS, Kopnin BP, Chumakov PM.

Mol Biol (Mosk). 2000 Mar-Apr;34(2):316-25. Russian. No abstract available.

PMID:
10779961
20.

[Effect of inactivating the p33ING1 tumor suppressor on the function of cell cycle "checkpoints" and genome stability].

Turovets NA, Agapova LS, Kopnin PB, Tulina NM, Chumakov PM, Kopnin BP.

Genetika. 2000 Mar;36(3):385-92. Russian.

PMID:
10779915

Supplemental Content

Loading ...
Support Center